HAS2 and central nervous system cancer: In addition, the hazard ratios of three lncRNAs (HAS2-AS1, PCBP1-AS1, and LINC02875) were >1 and correlated with the prognosis of glioma patients (Figures 7D–I and Supplementary Figure 2).